Trader Idea Feed: 'We took a look at the late-stage brain cancer pipeline, after $TOCA news and $ABBV and $BMY failures this month. And found only 5 active pivotal trials. Which includes $NWBO, so arguably only 4. Is $CELG the next big hope?' @ByAmyBrown
Benzinga Newsdesk